Search

everythinglearnresearchcommunity

for

Search:↓

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Skin symptoms without a medical cause often reflect psychological stress and are influenced by culture, requiring a team approach for treatment.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Treating skin conditions with both psychological and dermatological care improves patient outcomes and can save costs.

Doctors need to be better prepared to assess and treat obesity in patients.

People with androgenetic alopecia have more personality disorders and mental health symptoms; treatment may help.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Post-finasteride patients show changes in gut bacteria, possibly causing various symptoms.

Skin doctors should recognize and treat conditions like hair-pulling and skin-picking early, often using therapy and medication, to help 50-70% of patients.

More research is needed on CCCA in children, especially Black and Asian adolescents.

The article concludes that better diagnosis and management of Polycystic Ovarian Syndrome are needed to improve women's health and prevent related diseases.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Pediatric dermatologists need to understand the unique skin health needs of LGBTQIA youth to provide better care.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

The conclusion is that self-concept, shame, and emotion regulation are key factors in hoarding disorder, body dysmorphic disorder, and trichotillomania, and should be targeted in treatment and research.

Some skin patients have body image issues linked to social difficulties but want psychological help.

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

People with psoriasis and depression have lower BDNF levels, which could help measure depression in those with psoriasis.

The two-factor model fits better for Chinese patients' understanding of illness causes than the original four-factor model.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Higher stress levels are linked to more skin problems, especially in young women.

Female rats showed more panic-related behavior than males, influenced by hormonal cycles and certain drugs.